Combination of aspirin or naproxen with omerprazole for colorectal cancer chemoprevention with clinically relevant doses
Ended Awarded Last action
- Contract number
- HHSN26100003
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7 Part of University Of Oklahoma
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $598,079
Award facts
- Opportunity
-
- N01CN5500347 Solicitation number
- Preclinical PREVENT Cancer Program: Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Sep 25, 2015
- Preclinical PREVENT Cancer Program for Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Jan 5, 2015
- Contract value 100% obligated
- $598,079.38 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$25 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $598,104 |
About this award
This federal contract award, valued at $598,079.38, was issued by the National Cancer Institute (NCI) to the University of Oklahoma (OU) Health Sciences Center Division. The contract supports the "COMBINATION OF ASPIRIN OR NAPROXEN WITH OMERPRAZOLE FOR COLORECTAL CANCER CHEMOPREVENTION WITH CLINICALLY RELEVANT DOSES" effort under the NCI's Preclinical Prevent Cancer Program.
The contract is a delivery order placed against the NCI's broader "PREVENT Cancer Program (PREVENT)" indefinite delivery vehicle. It does not have a set-aside designation. As the prime contractor, OU will provide research services and support related to colorectal cancer chemoprevention. OU has significant experience as both a prime and subcontractor on federal medical research, healthcare, and education contracts and grants with various agencies, including the Departments of Veterans Affairs, Defense, and Health and Human Services.
Quick answers
Who was awarded contract HHSN26100003?
HHSN26100003 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 24, 2015.
How much is contract HHSN26100003 worth?
The government has obligated $598,079 on HHSN26100003.
Is contract HHSN26100003 an order under another contract?
Yes. HHSN26100003 is a delivery order under HHSN261201500038I, an indefinite delivery contract, on PREVENT Cancer Program (PREVENT).
Was contract HHSN26100003 competed?
The extent of competition for HHSN26100003 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award